SCHEMBL234836

SCHEMBL234836

COc1ccccc1-c1coc2c(O)c(O)ccc2c1=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 6/20 0.64
ALOX12 P18054 5/20 0.64
HSD17B10 Q99714 4/20 0.61
ALDH1A1 P00352 4/20 0.61
KDM4E B2RXH2 3/20 0.61
HPGD P15428 3/20 0.61
RCE1 Q9Y256 2/20 0.61
CYP3A4 P08684 2/20 0.61
SMN1; SMN2 Q16637 2/20 0.61
USP2 O75604 1/20 0.61
GLA P06280 1/20 0.61
XDH P47989 1/20 0.57
PFKFB3 Q16875 1/20 0.57
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
LMNA P02545 1/20 0.56
TP53 P04637 1/20 0.56
MAPT P10636 1/20 0.56
THRB P10828 1/20 0.56
PIK3CA P42336 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL236627 0.88 ALDH1A1 (0.60) ALOX15ALOX12HSD17B10ALDH1A1KDM4E
SCHEMBL18222914 0.85 HSD17B10 (0.69) HSD17B10ALDH1A1KDM4EHPGDRCE1
SCHEMBL30903615 0.85 HSD17B10 (0.69) HSD17B10ALDH1A1KDM4EHPGDRCE1
SCHEMBL18222890 0.84 KDM4E (0.67) ALOX15HSD17B10ALDH1A1KDM4EHPGD
SCHEMBL30903612 0.84 KDM4E (0.67) ALOX15HSD17B10ALDH1A1KDM4EHPGD
SCHEMBL234354 0.83 ALOX15 (0.75) ALOX15ALOX12HSD17B10ALDH1A1KDM4E
SCHEMBL30903592 0.82 KDM4E (0.74) HSD17B10ALDH1A1KDM4EHPGDRCE1
SCHEMBL12325242 0.82 KDM4E (0.74) HSD17B10ALDH1A1KDM4EHPGDRCE1
SCHEMBL10563073 0.81 MAPT (0.66) ALOX15ALOX12HSD17B10ALDH1A1KDM4E
SCHEMBL10562974 0.79 ALOX15 (1.00) ALOX15ALOX12HSD17B10ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120003273-A1 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGISTRATION OF SOCIETIES ACT (ACT XXI OF 1860)) (IN) 2012-01-05 US claimed
EP-2346844-A1 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS Council Of Scientific & Industrial Research (IN) 2011-07-27 EP claimed
WO-2010052734-A1 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2010-05-14 WO claimed
EP-2346844-B1 SUBSTITUTED BENZFUROCHROMENES FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS COUNCIL SCIENT IND RES (IN) 2017-09-20 EP disclosed
EP-2346844-B1 SUBSTITUTED BENZFUROCHROMENES FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS COUNCIL SCIENT IND RES (IN) 2017-09-20 EP disclosed
US-20120003273-A1 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGISTRATION OF SOCIETIES ACT (ACT XXI OF 1860)) (IN) 2012-01-05 US disclosed
US-20120003273-A1 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGISTRATION OF SOCIETIES ACT (ACT XXI OF 1860)) (IN) 2012-01-05 US disclosed
US-20120003273-A1 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGISTRATION OF SOCIETIES ACT (ACT XXI OF 1860)) (IN) 2012-01-05 US disclosed
EP-2346844-A1 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS Council Of Scientific & Industrial Research (IN) 2011-07-27 EP disclosed
WO-2010052734-A1 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2010-05-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120003273-A1 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS AKR1C3, AKR1C4, SLC10A1 ALOX15 1264/4885ALOX12 1465/4885HSD17B10 247/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.